Indigo
As of the edition of 20 October 2026, Indigo is a small molecule: marketed, first approved in 2013 (FR).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2013
- Kind
- Small molecule
- Brand name
- Carmyne
- First approved
- 12 August 2013 (FR)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Serb
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.